Legend Biotech (LEGN) Net Margin (2019 - 2026)
Legend Biotech's (LEGN) quarterly Net Margin came in at 18.03% in Q1 2026, up 3372.0% YoY from 0.52% in Q1 2025, and down 78.69% on a QoQ basis from 10.09% in Q4 2025.
Legend Biotech (LEGN) Net Margin (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 8 years of Net Margin data on file, last reported at 18.03% in Q1 2026.
- Quarterly Net Margin rose 3372.0% year-over-year to 18.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21.83% (up 1985.0% YoY) and the FY2025 annual result came in at 28.85%, up 125.0% from the prior year.
- Net Margin fell to 18.03% in Q1 2026, from 10.09% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 0.11% in Q4 2023 to a low of 1614.13% in Q2 2022.
- A 5-year average of 203.05% and a median of 63.62% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin sank 246707 bps — and 2023, when it surged 134258 bps.
- Tracing LEGN's Net Margin over 5 years: stood at 491.72% in 2022, then jumped by 100 bps to 0.11% in 2023, then tumbled by 28331 bps to 31.68% in 2024, then jumped by 68 bps to 10.09% in 2025, then tumbled by 79 bps to 18.03% in 2026.
- The last three Net Margin figures came in at 18.03% (Q1 2026), 10.09% (Q4 2025), and 14.12% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 8.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.57% |
| Mar 31, 2026 | -18.03% |
| Dec 31, 2025 | -10.09% |
| Sep 30, 2025 | -14.12% |
| Jun 30, 2025 | -48.70% |
| Mar 31, 2025 | -51.75% |
| Dec 31, 2024 | -31.68% |
| Sep 30, 2024 | -78.23% |
| Jun 30, 2024 | -9.76% |
| Mar 31, 2024 | -63.62% |
| Dec 31, 2023 | -0.11% |
| Sep 30, 2023 | -64.79% |
| Jun 30, 2023 | -271.55% |
| Mar 31, 2023 | -308.51% |
| Dec 31, 2022 | -491.72% |
| Sep 30, 2022 | -310.50% |
| Jun 30, 2022 | -1,614.13% |
| Mar 31, 2022 | -64.53% |
| Dec 31, 2021 | -226.53% |
| Sep 30, 2021 | -738.96% |